Medicina Interna HCSBA (@mhcsba) 's Twitter Profile
Medicina Interna HCSBA

@mhcsba

medicina-interna.org
Servicio de medicina interna - Cuenta exclusiva para formación académica

ID: 1205835274158260224

calendar_today14-12-2019 13:01:59

3,3K Tweet

8,8K Followers

165 Following

Aravind Palraj (@rheumat_aravind) 's Twitter Profile Photo

🧵 Top 10 Labs in Rheumatology — And How to Interpret Them Ordering is easy. Interpreting in context is where clinical medicine begins 👇 #Rheumatology #MedTwitter Dr Ihab Suliman Dr. Akhil 🇮🇳

Medicina Interna HCSBA (@mhcsba) 's Twitter Profile Photo

Cosas que hacemos sin razón 2025: Evadir el uso de medio de contraste en pacientes con falla renal aguda o enfermedad renal crónica DOI: 10.1002/jhm.70063 #MedED #MedTwitter #MedX

Cosas que hacemos sin razón 2025: Evadir el uso de medio de contraste en pacientes con falla renal aguda o enfermedad renal crónica
DOI: 10.1002/jhm.70063
#MedED #MedTwitter #MedX
Aravind Palraj (@rheumat_aravind) 's Twitter Profile Photo

🧵 “Steroid Tapering in Rheumatology: Art Meets Strategy” Steroids save lives — but tapering them wrong can lead to flares, adrenal crisis, or long-term toxicity. Here’s how to taper safely, sensibly, and successfully in autoimmune disease.👇 #Rheumatology #Steroids #MedTwitter

Ahmed Mohsen (@drahmedmohsen85) 's Twitter Profile Photo

💡 Steroidal vs Nonsteroidal MRAs in Heart Failure 💡(1) Not all MRAs are created equal! 🔴 Steroidal MRAs (Spironolactone, Eplerenone) ✅ Proven benefits in HFrEF (RALES, EMPHASIS-HF) ⚠️ Lower selectivity, more side effects (esp. hormonal) ⚠️ Higher risk of hyperkalemia.

💡 Steroidal vs Nonsteroidal MRAs in Heart Failure 💡(1)

Not all MRAs are created equal!

🔴 Steroidal MRAs (Spironolactone, Eplerenone)
✅ Proven benefits in HFrEF (RALES, EMPHASIS-HF)
⚠️ Lower selectivity, more side effects (esp. hormonal)
⚠️ Higher risk of hyperkalemia.
@carogomezmartin (@carogomezmartin) 's Twitter Profile Photo

🆕 Nuevos criterios de Cetoacidosis diabética. 👉🏻Hiperglucemia > 200 o antecedentes de #diabetes 📈 El ritmo de aumento de las cetonas es más importante que los valores absolutos. #ADASciSessions

🆕 Nuevos criterios de Cetoacidosis diabética. 

👉🏻Hiperglucemia > 200 o antecedentes de #diabetes 

📈 El ritmo de aumento de las cetonas es más importante que los valores absolutos.

#ADASciSessions
Abdelhamid Hamdy (@abdelhamed012) 's Twitter Profile Photo

What’s New in Heart Failure? • ARNI preferred (ESC), tracked (AHA), still 2nd-line (NICE) • SGLT2i now recommended in HFpEF by all • IV Iron endorsed across all • HFmrEF: 4-drug treatment endorsed • NICE: Flexible sequencing + 6-month follow-up

What’s New in Heart Failure? 

• ARNI preferred (ESC), tracked (AHA), still 2nd-line (NICE)
• SGLT2i now recommended in HFpEF by all
• IV Iron endorsed across all
• HFmrEF: 4-drug treatment endorsed
• NICE: Flexible sequencing + 6-month follow-up
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴Kidney Dysfunction in Heart Failure: Core Curriculum 2025 ⤵️ - American Journal of Kidney Diseases #openaccess 🔹ajkd.org/article/S0272-… #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX

🔴Kidney Dysfunction in Heart Failure: Core Curriculum 2025 ⤵️ - American Journal of Kidney Diseases #openaccess 

🔹ajkd.org/article/S0272-…
 #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros  #MedX
KDIGO (@gokdigo) 's Twitter Profile Photo

KDIGO is pleased to share the newly published report from its Controversies Conference on Preventing CKD and Maintaining Kidney Health, now available in press in Kidney International. 📄Download the report: kdigo.co/2025-CKD-Preve… 📘 Read the report in KI: kdigo.co/KDIGO-2025-CKD…

KDIGO is pleased to share the newly published report from its Controversies Conference on Preventing CKD and Maintaining Kidney Health, now available in press in <a href="/Kidney_Int/">Kidney International</a>.

📄Download the report: kdigo.co/2025-CKD-Preve…
📘 Read the report in KI: kdigo.co/KDIGO-2025-CKD…
Edgar V. Lerma 🇵🇭 (@edgarvlermamd) 's Twitter Profile Photo

Preventing chronic kidney disease and maintaining kidney health: conclusions from KDIGO Controversies Conference ca. 2025 #Nephpearls 👉🏼 pubmed.ncbi.nlm.nih.gov/40536455/

Preventing chronic kidney disease and maintaining kidney health: conclusions from <a href="/goKDIGO/">KDIGO</a> Controversies Conference ca. 2025 #Nephpearls

👉🏼 pubmed.ncbi.nlm.nih.gov/40536455/
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴2025 ACC Guidelines for Cardiogenic Shock⤵️ 🔹jacc.org/doi/10.1016/j.… #MedEd #MedX #Diagnosis #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical

🔴2025 ACC Guidelines for Cardiogenic Shock⤵️ 

🔹jacc.org/doi/10.1016/j.…
#MedEd #MedX #Diagnosis
 #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros  #MedX #cardiovascular #MedTwitter #medical
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴Beta Blockers in Cirrhosis💊❤️⤵️ 🔹Credit: American College of Gastroenterology #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd

🔴Beta Blockers in Cirrhosis💊❤️⤵️ 

🔹Credit: American College of Gastroenterology  
 #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros  #MedX #cardiovascular #MedTwitter #medical #medEd
Medicina Interna HCSBA (@mhcsba) 's Twitter Profile Photo

Nature Reviews: patogénesis, presentación clínica y tratamiento de vasculitis sistémicas monogénicas doi.org/10.1038/s41584… #MedEd #MedTwitter #MedX

Nature Reviews: patogénesis, presentación clínica y tratamiento de vasculitis sistémicas monogénicas
 doi.org/10.1038/s41584…
#MedEd #MedTwitter #MedX
Sochinf (@sochinfoficial) 's Twitter Profile Photo

Recordamos el grupo recomendado para vacunación de Sarampión a las nacidos entre el año 1971 y 1981. Pero si usas algún medicamento inmunosupresor o tienes alguna condición que afecte tu sistema inmune, consulta antes con tu médico si es que puedes vacunarte. #sarampion

Recordamos el grupo recomendado para vacunación  de Sarampión a las nacidos entre el año 1971 y 1981.  Pero si usas algún medicamento inmunosupresor o tienes alguna condición que afecte tu sistema inmune, consulta antes con tu médico si es que puedes vacunarte.

#sarampion